Gallus inks manufacturing deal with Genzyme; Medidata lures Daiichi Sankyo;

> Vivus ($VVUS) has selected Sanofi's ($SNY) contract manufacturing unit to produce its recently approved Spedra. Article

> Clinical trial software outfit Medidata ($MDSO) has signed a deal with Japanese pharma giant Daiichi Sankyo. More

> Gallus BioPharmaceuticals has inked a multi-year deal with Genzyme to develop and manufacture a new protein therapy. Story

> Scientific software contractor Accelrys ($ACCL) is lopping off 80 jobs amid flattening revenue. News

> CRO Novum has recruited PRACS Institute veteran Alan Copa to serve as vice president and lead clinical expansion. Announcement

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.